Company Overview and News

to your dashboard

Headline News

Restasis Buyers Hit Allergan With An Anti-Trust Lawsuit

2017-11-22 seekingalpha
Allergan (AGN) simply cannot escape patent drama related to its blockbuster dry eye drug Restasis. Restasis buyers recently hit Allergan with an anti-trust lawsuit, claiming the company blocked low-cost generics from entering the market: (68-0)

Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q3 2017 Update

2017-11-22 seekingalpha
Wallace Weitz's 13F portfolio value increased from $2.32B to $2.43B. The number of positions increased from 74 to 79. (786-0)

Teva Pharmaceutical: Generidiculous!

2017-11-21 seekingalpha
Sure, Teva's growth trajectory has stalled with exclusivity loss of Copaxone and a $6.1 billion impairment charge but 4.6x 2018 EPS estimates? Really? (206-0)

15 Current Wall Street Favorites - Cramer's Mad Money (11/20/17)

2017-11-21 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Monday, November 20. (286-0)

Tracking The Parnassus Core Equity Fund - Q3 2017 Update

2017-11-20 seekingalpha
Including dividends, total return for the 3rd quarter was 3.34% vs. 4.48% for the S&P 500 and 3.55% for the Lipper Equity Income Fund Average. (333-1)

Why Fitch Sacked Teva

2017-11-20 seekingalpha
Generic Copaxone could cause Copaxone sales to decline by 70% and total EBITDA to fall by 34%. (365-3)

Tracking David Tepper's Appaloosa Management Portfolio - Q3 2017 Update

2017-11-19 seekingalpha
Appaloosa increased Micron Technology, Facebook, NRG Energy, and Apple while reducing Allergan plc, Williams Partners LP, and Energy Transfer Partners LP. (1522-7)

Tracking John Paulson's Paulson & Company Portfolio - Q3 2017 Update

2017-11-18 seekingalpha
Paulson & Company's largest three positions are the SPDR Gold ETF, Shire plc, and Mylan NV. (1155-10)

AGN / Allergan plc - Stock Institutional Ownership and Shareholders -

Allergan plc (NYSE:AGN) has 1138 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 223,596,496 shares. Largest shareholders include Vanguard Group Inc, Wellington Management Group Llp, State Street Corp, FMR LLC / Fidelity Management & Research, and Clearbridge Investments, LLC. (79-1)

Valeant: A Look At The Positives

2017-11-16 seekingalpha
Those who follow me know that I have traded in and out of Valeant (VRX) several times this year. At the beginning of the year I made the bold call that Valeant would end this year at around $30 per share. I was personally involved on Valeant with July calls with a $15 strike and I closed the trade for a 2.3x return. I always recommend my readers to take safer bets and for that reason I recommended investors selling January 2018 $20 puts for a net entry price of $11. (69-0)

Allergan's Vraylar Gets FDA Nod for Maintenance Therapy

2017-11-14 zacks
Allergan plc (AGN - Free Report) announced that the FDA has approved its supplemental New Drug Application (sNDA) for label expansion of its schizophrenia capsule, Vraylar (cariprazine), for maintenance treatment. (148-0)

Deals of the day-Mergers and acquisitions

2017-11-14 reuters
Nov 14 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1100 GMT on Tuesday: (259-3)

Tracking Seth Klarman's Baupost Group Holdings - Q3 2017 Update

2017-11-14 seekingalpha
The portfolio continues to be heavily concentrated, with the top three positions accounting for one-third of the 13F portfolio. (514-7)

Amgen Gets Positive CHMP Opinion to Expand Nplate's Label

2017-11-13 zacks
Amgen, Inc. (AMGN - Free Report) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a positive opinion to expand the label of Nplate to include the pediatric population. (209-0)

Municipal Bonds: A Market In Motion

2017-11-13 seekingalpha
I summarized recently the tax-exempt and tax-advantaged bond provisions of the Tax Cuts and Jobs Act H.R. 1, as introduced and referred to by the House Ways and Means Committee. As a reminder, these provisions would eliminate the ability of state and local governmental units to issue: (1) tax-exempt qualified private activity bonds, including qualified 501c3 bonds); (2) tax-exempt advance refunding bonds; (3) tax-exempt professional sports stadium bonds; and (4) tax credit bonds, regardless of whether the bondholder receives a tax credit or the issuer receives a direct payment subsidy, in respect of the tax credit bond. (125-1)

CUSIP: G0177J108